Inventor · disambiguated record
Steven A. Middleton
Also filed as: MIDDLETON STEVEN A
22 granted patents·6 pending applications·221 citations·filing 1997–2012
94Inventor score
Files withJANSSEN PHARMACEUTICA NV15CONNOLLY PETER J2ORTHO MCNEIL PHARM INC2BATTISTA KATHLEEN1BATTISTA KATHLEEN A1
Top patents by PatentIndex Score
28 records- 0196US7541367B23-benzoimidazolyl-pyrazolopyridines useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 2, 2009·104 cites·38 claims
- 0289US7855205B2Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Dec 21, 2010·9 cites·88 claims
- 0386US7317031B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2005·Granted Jan 8, 2008·5 cites·11 claims
- 0484US7582649B2Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disordersJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 1, 2009·7 cites·14 claims
- 0583US6924302B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 2, 2005·21 cites·12 claims
- 0682US7655670B23-spirocyclic indolyl derivatives useful as ORL-1 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Feb 2, 2010·8 cites·4 claims
- 0779US7081463B2Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disordersJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 25, 2006·11 cites·15 claims
- 0875US8153791B2Substituted pyrimidinyl oxime kinase inhibitorsXU GUOZHANG·Filed 2006·Granted Apr 10, 2012·5 cites·24 claims
- 0975US7888380B21,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 15, 2011·2 cites·27 claims
- 1072US6221608B1Methods for identifying erythropoietin receptor binding proteinORTHO PHARMA CORP·Filed 1997·Granted Apr 24, 2001·46 cites·1 claims
- 1171US7605154B2Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 20, 2009·2 cites·5 claims
- 1267US8778956B2Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disordersBATTISTA KATHLEEN·Filed 2008·Granted Jul 15, 2014·1 cites·15 claims
- 1360US7427625B2Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 23, 2008·0 cites·19 claims
- 1460US2008300264A1Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsCONNOLLY PETER J·Filed 2008·Application pending·0 cites
- 1559US2005266575A1Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimicsMAYO KEVIN H·Filed 2004·Application pending·0 cites
- 1657US7459557B2Substituted isoindole-1,3-dionesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Dec 2, 2008·0 cites·1 claims
- 1748US7517885B2Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compoundsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Apr 14, 2009·0 cites·9 claims
- 1847US8314234B2Bicyclic pyrimidine kinase inhibitorsCONNOLLY PETER J·Filed 2007·Granted Nov 20, 2012·0 cites·7 claims
- 1946US7109220B2Amino substituted pyridinyl methanone compounds useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 19, 2006·0 cites·10 claims
- 2045US8367825B2Substituted pyrimidinyl oxime kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Feb 5, 2013·0 cites·13 claims
- 2143US8299082B21,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivativesHUANG SHENLIN·Filed 2010·Granted Oct 30, 2012·0 cites·2 claims
- 2243US7482348B2Piperazinyl substituted cyclohexane-1,4-diaminesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jan 27, 2009·0 cites·3 claims
- 2343US2008108611A1Substituted thienopyrimidine kinase inhibitorsBATTISTA KATHLEEN A·Filed 2007·Application pending·0 cites
- 2442US7659284B2Thiazolopyridine kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 9, 2010·0 cites·13 claims
- 2542US2006173015A1Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptomsCHIU GEORGE·Filed 2005·Application pending·0 cites
- 2641US7470711B2Piperidinyl substituted cyclohexane-1,4-diaminesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Dec 30, 2008·0 cites·7 claims
- 2739US2006183902A1Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptomsBAXTER ELLEN W·Filed 2006·Application pending·0 cites
- 2836US2008015214A13-piperidin-4-yl-indole orl-1 receptor modulatorsBIGNAN GILLES C·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven A. Middleton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →